Profusa stock, preferred, $7 m convert financing for non-binding acquisition term sheet

 

Profusa details stock, preferred equity and $7 million convertible note financing for non-binding term sheet to acquire $111 million‑revenue diagnostics and toxicology firm

• Profusa appoints Jack Stover as Executive Chairman and CEO and reshapes its board of directors.

https://finviz.com/stock?t=PFSA&p=d